Lifebit articles
What is the Clinical Data Interchange Standards Consortium?
The Clinical Data Interchange Standards Consortium (CDISC) is a global, not-for-profit organisation that develops data standards across all the healthcare sector. Founded in 1997, over the last 20+ years CDISC has provided guidance on the transformation of clinical data from incompatible into interoperable formats so that it is usable,
A growing number of governments, pharmaceutical companies and research organisations are choosing Lifebit for its secure, cutting-edge platform and visionary team.
Lifebit is pleased to spotlight Brian Longo, who has joined as Lifebit’s Executive Strategic Advisor. Responsible for guiding the design and execution of Lifebit’s rapidly scaling operating models and processes, Bria
The Danish National Genome Center has awarded Lifebit a four-year contract to implement Lifebit’s Federated Trusted Research Environment software, Lifebit CloudOS, within Denmark`s national supercomputing center.
LONDON, UK - 28 April 2022 – Lifebit, whose leading technology enables secure analysis over sensitive datasets for researchers and interconnects such large patient cohorts worldwide, today announces a long-term partnership with the Danish National Gen
Genome initiatives spearheaded by burgeoning numbers of data custodians such as Genomics England (GEL), a Lifebit customer, leverage technological advances to amass large volumes of patient data. As a result, data custodians are veritable gold mines of genome data that could transform precision medicine and provide an equitable solution for diverse healthcare requirements. Pharmaceutical companies recognize the growing value of genome data, partnering with biobanks to power
The Covid-19 pandemic highlighted the disparity between those who succumbed to severe illness while others remained relatively unaffected, underscoring the urgent need to shift the healthcare industry’s focus from a one-size-fits-all approach to more personalised healthcare.
Personalised medicine promises to transform healthcare with treatments tailored to a patient’s unique genetic profile (genomics) and by leveraging their genomic data to predict